Farrer LA. Genetics and the dementia patient. Neurologist.1997;3:13-30.
Farrer LA, Cupples LA, Haines JL.
et al. Effects of age, sex and ethnicity on the association between apolipoprotein
E genotype and Alzheimer disease: a meta-analysis. JAMA.1997;278:1349-1356.
Van Duijn CM, Farrer LA, Cupples LA, Hofman A. Genetic transmission for Alzheimer's disease among families in a Dutch
population based survey. J Med Genet.1993;30:640-646.
Silverman JM, Li G, Zaccario ML.
et al. Patterns of risk in first-degree relatives of patients with Alzheimer's
disease. Arch Gen Psychiatry.1994;51:577-586.
Farrer LA, Cupples LA, van Duijn CM.
et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications
for the risk of dementia among relatives. Ann Neurol.1995;38:797-808.
Lautenschlager NT, Cupples LA, Rao VS.
et al. Risk of dementia among relatives of Alzheimer's disease patients in
the MIRAGE study: what is in store for the oldest old? Neurology.1996;46:641-650.
Jorm AF, Jolly D. The incidence of dementia: a meta-analysis. Neurology.1998;51:728-733.
Gao S, Hendrie HC, Hall KS, Hui S. The relationships between age, sex, and the incidence of dementia and
Alzheimer disease: a meta-analysis. Arch Gen Psychiatry.1998;55:809-815.
Hendrie HC, Ogunniyi A, Hall KS.
et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba
residing in Ibadan, Nigeria, and African Americans residing in Indianapolis,
Graff-Radford N, Green RC, Go R.
et al. Association between APOE genotype and Alzheimer
disease in African Americans. Arch Neurol.In press.
Farrer LA, Cupples LA, Blackburn S.
et al. Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE
Demissie S, Green RC, Mucci L.
et al. Reliability of information collected by proxy in family studies of
Alzheimer's disease. Neuroepidemiology.2001;20:105-111.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA
Work Group. Neurology.1984;34:939-944.
Guo Z, Cupples LA, Kurz A.
et al. Head injury and the risk of Alzheimer disease in the MIRAGE study. Neurology.2000;54:1316-1323.
Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol.1988;1:111-117.
Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive
status. Neuropsychiatry Neuropsychol Behav Neurol.1993;6:103-110.
Not Available. Census of Population and Housing: 1990 Summary Tape File 1, Technical
Documentation. Washington, DC: US Bureau of the Census; 1991.
Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet.1991;337:1158-1159.
Cupples LA, Risch N, Farrer LA, Myers RH. Estimation of morbid risk and age at onset with missing information. Am J Hum Genet.1991;49:76-87.
Devi G, Ottman R, Tang M.
et al. Influence of APOE genotype on familial aggregation
of AD in an urban population. Neurology.1999;53:789-794.
Devi G, Ottman R, Tang MX, Marder K, Stern Y, Mayeux R. Familial aggregation of Alzheimer disease among whites, African Americans,
and Caribbean Hispanics in northern Manhattan. Arch Neurol.2000;57:72-77.
Belgrave LL, Wykle ML, Choi JM. Health, double jeopardy, and culture: the use of institutionalization
by African-Americans. Gerontologist.1993;33:379-385.
Ballard EL, Nash F, Raiford K, Harrell LE. Recruitment of black elderly for clinical research studies of dementia:
the CERAD experience. Gerontologist.1993;33:561-565.
Connell CM, Gibson GD. Racial, ethnic and cultural differences in dementia caregiving: review
and analysis. Gerontologist.1997;37:355-364.
Silverman JM, Breitner JC, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's
disease and related dementias. Am J Psychiatry.1986;143:1279-1282.
Devi G, Marder K, Schofield PW.
et al. Validity of family history for the diagnosis of dementia among siblings
of patients with late-onset Alzheimer's disease. Genet Epidemiol.1998;15:215-223.
Gurland BJ, Wilder DE, Lantigua R.
et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry.1999;14:481-493.
Tang MX, Stern Y, Marder K.
et al. The APOE-e4 allele and the risk of Alzheimer
disease among African Americans, whites, and Hispanics. JAMA.1998;279:751-755.
Tang MX, Cross P, Andrews H.
et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians
in northern Manhattan. Neurology.2001;56:49-56.
Maestre G, Ottman R, Stern Y.
et al. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic
risks. Ann Neurol.1995;37:254-259.
Tang MX, Maestre G, Tsai WY.
et al. Effect of age, ethnicity, and head injury on the association between
APOE genotypes and Alzheimer's disease. Ann N Y Acad Sci.1996;802:6-15.
Sahota A, Yang M, Gao S.
et al. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American
population is genotype dependent. Ann Neurol.1997;42:659-661.
Osuntokun BO, Sahota A, Ogunniyi AO.
et al. Lack of an association between Apolipoprotein E epsilon 4 and Alzheimer's
disease in elderly Nigerians. Ann Neurol.1995;38:463-465.
Sayi JG, Patel NB, Premkumar DR.
et al. Apolipiprotein E polymorphism in elderly East Africans. East Afr Med J.1997;74:668-670.
Farrer LA, Brin MF, Elsas L.
et al. Statement on use of Apolipoprotein E testing for Alzheimer disease. JAMA.1995;274:1627-1629.
Lovestone S. The genetics of Alzheimer's disease: new opportunities and new challenges. Int J Geriatr Psychiatry.1995;10:1-7.
Brodary H, Conneally M, Gauthier S.
et al. Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc Disord.1995;9:182-187.
Relkin NR, Gandy S. Consensus statements on the use of APOE genotyping in Alzheimer's disease. Neurol Alert.1996;14:58-59.
Post SG, Whitehouse PJ, Binstock RH.
et al. The clinical introduction of genetic testing for Alzheimer's disease:
an ethical perspective. JAMA.1997;277:832-836.
McConnell LM, Koenig BA, Greely HT.
et al. Genetic testing and Alzheimer disease: has the time come?
Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society. Nat Med.1998;4:757-759.